These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Detection of BRAF V600E mutation in thyroid fine-needle aspiration specimens by High Resolution Melting (HRM) analysis.
    Author: Nechifor-Boilă A, Decaussin-Petrucci M, Gazzo S, Paşcanu I, Borda A.
    Journal: Rom J Morphol Embryol; 2012; 53(2):263-7. PubMed ID: 22732794.
    Abstract:
    AIM: The aim of our study was to test the feasibility of High Resolution Melting (HRM) analysis for detection of BRAF V600E mutation in various types of fine-needle aspiration (FNA) specimens from patients with papillary thyroid carcinoma (PTC). MATERIALS AND METHODS: We analyzed fresh thyroid aspirates and smears from eight cases of PTC: three classic PTCs (CPTC), three follicular variant of PTCs (FVPTC), one tall cell, and one oncocytic variant of PTC. DNA extraction was performed using a MasterPure purification kit. The isolated DNA quantity was assessed using a NanoDrop spectrophotometer and the DNA quality was tested by PCR amplification of β-globin gene and by native DNA electrophoresis. HRM was performed on a LightCycler 480 (Roche). We amplified the 15th exon of BRAF gene, using selected primers to flank the BRAF V600E mutation point. RESULTS: For all types of cytological specimens, the quantity of isolated DNA was adequate and allowed amplification. Similarly, the DNA quality control did not show signs of DNA degradation and the DNA was amplifiable for β-globin gene. Four cases revealed the BRAF V600E mutation: two CPTCs, one oncocytic PTC, one tall cell PTC. None of the three cases of FVPTC had this mutation. CONCLUSIONS: HRM analysis represents a feasible and reproducible molecular technique, offering new perspectives for detecting BRAF mutation in various FNA specimens. In our study, BRAF V600E mutation revealed a strong association with specific histological variants of PTC: highly specific for CPTC, tall cell or oncocytic PTC, but negative in all cases of FVPTC.
    [Abstract] [Full Text] [Related] [New Search]